Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care

Borwin BandelowDepartment of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, GermanyCorrespondence[email protected]

Leo SherAlbert Einstein College of Medicine and Montefiore Medical Center, New York City, NY, USA

Robertas BuneviciusInstitute of Psychophysiology and Rehabilitation, Lithuanian University of Health Sciences, Palanga, Lithuania

Eric HollanderAlbert Einstein College of Medicine and Montefiore Medical Center, New York City, NY, USA

Siegfried KasperDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria

Joseph ZoharDivision of Psychiatry, Chaim-Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel

Hans-Jürgen MöllerDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany

, WFSBP Task Force on Mental Disorders in Primary Care & WFSBP Task Force on Anxiety Disorders, OCD and PTSD show all

References

Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Allgulander C, . World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry 2008;9(4):248–312.
PubMed Web of Science ®Google Scholar
WHO. World Health Organisation. Tenth Revision of the International Classification of Diseases, Chapter V (F): Mental and Behavioural Disorders (including disorders of psychological development). Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation; 1991.
Google Scholar
APA. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision (DSM-IV-TR®). Washington, DC: American Psychiatric Press; 2000.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date